|
1
|
Hansson GK and Libby P: The immune
response in atherosclerosis: A double-edged sword. Nat Rev Immunol.
6:508–519. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hansson GK: Inflammation, atherosclerosis,
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bobryshev YV: Monocyte recruitment and
foam cell formation in atherosclerosis. Micron. 37:208–222. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mangge H, Hubmann H, Pilz S, Schauenstein
K, Renner W and März W: Beyond cholesterol-inflammatory cytokines,
the key mediators in atherosclerosis. Clin Chem Lab Med.
42:467–474. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kleemann R, Zadelaar S and Kooistra T:
Cytokines and atherosclerosis: A comprehensive review of studies in
mice. Cardiovasc Res. 79:360–376. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Singer NG and Caplan AI: Mesenchymal stem
cells: Mechanisms of inflammation. Annu Rev Pathol. 6:457–478.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Frodermann V, van Duijn J, van Pel M, van
Santbrink PJ, Bot I, Kuiper J and de Jager SC: Mesenchymal stem
cells reduce murine atherosclerosis development. Sci Rep.
5:155592015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bura A, Planat-Benard V, Bourin P,
Silvestre JS, Gross F, Grolleau JL, Saint-Lebese B, Peyrafitte JA,
Fleury S, Gadelorge M, et al: Phase I trial: The use of autologous
cultured adipose-derived stroma/stem cells to treat patients with
non-revascularizable critical limb ischemia. Cytotherapy.
16:245–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vega A, Martin-Ferrero MA, Del Canto F,
Alberca M, García V, Munar A, Orozco L, Soler R, Fuertes JJ, Huguet
M, et al: Treatment of knee osteoarthritis with allogeneic bone
marrow mesenchymal stem cells: A randomized controlled trial.
Transplantation. 99:1681–1690. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin YL, Yet SF, Hsu YT, Wang GJ and Hung
SC: Mesenchymal stem cells ameliorate atherosclerotic lesions via
restoring endothelial function. Stem Cells Transl Med. 4:44–55.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wagner W, Bork S, Horn P, Krunic D,
Walenda T, Diehlmann A, Benes V, Blake J, Huber FX, Eckstein V, et
al: Aging and replicative senescence have related effects on human
stem and progenitor cells. PLoS One. 4:e58462009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kretlow JD, Jin YQ, Liu W, Zhang WJ, Hong
TH, Zhou G, Baggett LS, Mikos AG and Cao Y: Donor age and cell
passage affects differentiation potential of murine bone
marrow-derived stem cells. BMC Cell Biol. 9:602008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu J, Vodyanik MA, Smuga-Otto K,
Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA,
Ruotti V, Stewart R, et al: Induced pluripotent stem cell lines
derived from human somatic cells. Science. 318:1917–1920. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takahashi K, Tanabe K, Ohnuki M, Narita M,
Ichisaka T, Tomoda K and Yamanaka S: Induction of pluripotent stem
cells from adult human fibroblasts by defined factors. Cell.
131:861–872. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X,
Zhang Y, Lam FF, Kang S, Xia JC, Lai WH, et al: Functional
mesenchymal stem cells derived from human induced pluripotent stem
cells attenuate limb ischemia in mice. Circulation. 121:1113–1123.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun YQ, Deng MX, He J, Zeng QX, Wen W,
Wong DS, Tse HF, Xu G, Lian Q, Shi J and Fu QL: Human pluripotent
stem cell-derived mesenchymal stem cells prevent allergic airway
inflammation in mice. Stem Cells. 30:2692–2699. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Diederichs S and Tuan RS: Functional
comparison of human-induced pluripotent stem cell-derived
mesenchymal cells and bone marrow-derived mesenchymal stromal cells
from the same donor. Stem Cells Dev. 23:1594–1610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Liang X, Liao S, Wang W, Wang J,
Li X, Ding Y, Liang Y, Gao F, Yang M, et al: Potent paracrine
effects of human induced pluripotent stem cell-derived mesenchymal
stem cells attenuate doxorubicin-induced cardiomyopathy. Sci Rep.
5:112352015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang QZ, Su WR, Shi SH, Wilder-Smith P,
Xiang AP, Wong A, Nguyen AL, Kwon CW and Le AD: Human
gingiva-derived mesenchymal stem cells elicit polarization of m2
macrophages and enhance cutaneous wound healing. Stem Cells.
28:1856–1868. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Q, Sun W, Wang X, Zhang K, Xi W and Gao
P: Skin-derived mesenchymal stem cells alleviate atherosclerosis
via modulating macrophage function. Stem Cells Transl Med.
4:1294–1301. 2015. View Article : Google Scholar :
|
|
21
|
Galkina E and Ley K: Immune and
inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol.
27:165–197. 2009. View Article : Google Scholar :
|
|
22
|
Stary HC, Chandler AB, Dinsmore RE, Fuster
V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD and
Wissler RW: A definition of advanced types of atherosclerotic
lesions and a histological classification of atherosclerosis. A
report from the committee on vascular lesions of the council on
arteriosclerosis, American heart association. Arterioscler Thromb
Vasc Biol. 15:1512–1531. 1995. View Article : Google Scholar
|
|
23
|
Moreno PR, Falk E, Palacios IF, Newell JB,
Fuster V and Fallon JT: Macrophage infiltration in acute coronary
syndromes. Implications for plaque rupture. Circulation.
90:775–778. 1994. View Article : Google Scholar
|
|
24
|
Zhou J, Lhoták S, Hilditch BA and Austin
RC: Activation of the unfolded protein response occurs at all
stages of atherosclerotic lesion development in apolipoprotein
E-deficient mice. Circulation. 111:1814–1821. 2005. View Article : Google Scholar
|
|
25
|
Baigent C, Keech A, Kearney PM, Blackwell
L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R and
Simes R: Cholesterol Treatment Trialists' (CTT) Collaborators:
Efficacy and safety of cholesterol-lowering treatment: Prospective
meta-analysis of data from 90,056 participants in 14 randomised
trials of statins. Lancet. 366:1267–1278. 2005. View Article : Google Scholar
|
|
26
|
van Diepen JA, Berbée JF, Havekes LM and
Rensen PC: Interactions between inflammation and lipid metabolism:
Relevance for efficacy of anti-inflammatory drugs in the treatment
of atherosclerosis. Atherosclerosis. 228:306–315. 2013. View Article : Google Scholar
|
|
27
|
Besler C, Heinrich K, Rohrer L, Doerries
C, Riwanto M, Shih DM, Chroni A, Yonekawa K, Stein S, Schaefer N,
et al: Mechanisms underlying adverse effects of HDL on
eNOS-activating pathways in patients with coronary artery disease.
J Clin Invest. 121:2693–2708. 2011. View
Article : Google Scholar :
|
|
28
|
Vuilleumier N, Dayer JM, von Eckardstein A
and Roux-Lombard P: Pro- or anti-inflammatory role of
apolipoprotein A-1 in high-density lipoproteins? Swiss Med Wkly.
143:w137812013.
|
|
29
|
Rizzo M, Otvos J, Nikolic D, Montalto G,
Toth PP and Banach M: Subfractions and subpopulations of HDL: An
update. Curr Med Chem. 21:2881–2891. 2014. View Article : Google Scholar
|
|
30
|
Von Feldt JM: High-density lipoprotein:
Does it have a dark side? Arthritis Res Ther. 10:1212008.
View Article : Google Scholar :
|
|
31
|
Skaggs BJ, Hahn BH, Sahakian L, Grossman J
and McMahon M: Dysfunctional, pro-inflammatory HDL directly
upregulates monocyte PDGFRβ, chemotaxis and TNFα production. Clin
Immunol. 137:147–156. 2010. View Article : Google Scholar :
|
|
32
|
Ansell BJ, Fonarow GC and Fogelman AM: The
paradox of dysfunctional high-density lipoprotein. Curr Opin
Lipidol. 18:427–434. 2007. View Article : Google Scholar
|
|
33
|
Khan DA, Ansari WM and Khan FA:
Pro/anti-inflammatory cytokines in the pathogenesis of premature
coronary artery disease. J Interferon Cytokine Res. 31:561–567.
2011. View Article : Google Scholar
|
|
34
|
Wang XH, Liu SQ, Wang YL and Jin Y:
Correlation of serum high-sensitivity C-reactive protein and
interleukin-6 in patients with acute coronary syndrome. Genet Mol
Res. 13:4260–4266. 2014. View Article : Google Scholar
|
|
35
|
Hashizume R, Yamawaki-Ogata A, Ueda Y,
Wagner WR and Narita Y: Mesenchymal stem cells attenuate
angiotensin II-induced aortic aneurysm growth in apolipoprotein
E-deficient mice. J Vasc Surg. 54:1743–1752. 2011. View Article : Google Scholar
|
|
36
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar
|
|
37
|
Liu ZJ, Tan Y, Beecham GW, Seo DM, Tian R,
Li Y, Vazquez-Padron RI, Pericak-Vance M, Vance JM,
Goldschmidt-Clermont PJ, et al: Notch activation induces
endothelial cell senescence and pro-inflammatory response:
Implication of Notch signaling in atherosclerosis. Atherosclerosis.
225:296–303. 2012. View Article : Google Scholar :
|
|
38
|
Aquila G, Pannella M, Morelli MB, Caliceti
C, Fortini C, Rizzo P and Ferrari R: The role of Notch pathway in
cardiovascular diseases. Glob Cardiol Sci Pract. 2013:364–371.
2013.
|
|
39
|
Xu H, Zhu J, Smith S, Foldi J, Zhao B,
Chung AY, Outtz H, Kitajewski J, Shi C, Weber S, et al: Notch-RBP-J
signaling regulates the transcription factor IRF8 to promote
inflammatory macrophage polarization. Nat Immunol. 13:642–650.
2012. View Article : Google Scholar :
|
|
40
|
Qiu X, Zhang S, Zhao X, Fu K and Guo H:
The therapeutic effect of adipose-derived mesenchymal stem cells
for radiation-induced bladder injury. Stem Cells Int.
2016:36790472016. View Article : Google Scholar :
|
|
41
|
Müller-Ehmsen J, Whittaker P, Kloner RA,
Dow JS, Sakoda T, Long TI, Laird PW and Kedes L: Survival and
development of neonatal rat cardiomyocytes transplanted into adult
myocardium. J Mol Cell Cardiol. 34:107–116. 2002. View Article : Google Scholar
|
|
42
|
Toma C, Pittenger MF, Cahill KS, Byrne BJ
and Kessler PD: Human mesenchymal stem cells differentiate to a
cardiomyocyte phenotype in the adult murine heart. Circulation.
105:93–98. 2002. View Article : Google Scholar
|
|
43
|
Pushpan CKVSGS and Rathnam PAJAH:
Attenuation of atherosclerotic complications by modulating
inflammatory responses in hypercholesterolemic rats with dietary
Njavara rice bran oil. Biomed Pharmacother. 83:1387–1397. 2016.
View Article : Google Scholar
|
